Leeds General Infirmary, also known as the LGI, is a large teaching hospital based in the centre of Leeds, West Yorkshire, England, and is part of the Leeds Teaching Hospitals NHS Trust. Its previous name The General Infirmary at Leeds is still sometimes used.

There are 1,103 beds in Leeds General Infirmary, D Floor Brotherton Wing.

During the past decade, Leeds General Infirmary, D Floor Brotherton Wing conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Leeds General Infirmary, D Floor Brotherton Wing" are "Hemoglobinuria, Paroxysmal" (2 trials) and "Paroxysmal Hemoglobinuria, Nocturnal" (1 trials). Many other conditions were trialed in "Leeds General Infirmary, D Floor Brotherton Wing" in a lesser frequency.

Most popular intervention types in "Leeds General Infirmary, D Floor Brotherton Wing" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "eculizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Leeds General Infirmary, D Floor Brotherton Wing" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Leeds General Infirmary, D Floor Brotherton Wing". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Leeds General Infirmary, D Floor Brotherton Wing, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leeds General Infirmary, D Floor Brotherton Wing, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".